 Consents and base line measures will be obtained. The TMS and standard medication therapy subjects will be selected from a patient population with at one to three less than adequate responses to standard medication therapy. One group 15 patients will receive TMS as well as standard medication therapy and the other group 15 patients will continue with their current medication. 